Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment

PURPOSE: To investigate the effectiveness of mineralocorticoid receptor (MR) antagonist in patients with steroid-induced central serous chorioretinopathy (CSC). METHODS: A retrospective review was conducted of steroid-induced CSC patients who were treated with the MR antagonist spironolactone 50 mg...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Ophthalmol
Huvudupphovsmän: Kim, Jin Young, Chae, Ju Byung, Kim, Jisoo, Kim, Dong Yoon
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi 2018
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081588/
https://ncbi.nlm.nih.gov/pubmed/30140452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4258763
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk